Yu, Dong
Dynavax Technologies (United States)
5 papers on CoChatORCID 0000-0002-3412-6440
Most cited papers
- Verified
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
Maruggi, G., Zhang, C., Li, J., Ulmer, J. B., & Yu, D. (2019) · Molecular Therapy
RNA Interference and Gene DeliveryImmunotherapy and Immune Responses
Cited by 507
- Verified
Mechanism of action of mRNA-based vaccines
Iavarone, C., O’hagan, D. T., Yu, D., Delahaye, N. F., & Ulmer, J. B. (2017) · Expert Review of Vaccines
Immunotherapy and Immune ResponsesRNA Interference and Gene Delivery
Cited by 234
- Verified
Induction of an IFN-mediated antiviral response by a self-amplifying RNA vaccine: implications for vaccine design
Pepini, T., Pulichino, A.-M., Carsillo, T., Carlson, A. L., Sari-Sarraf, F., Ramsauer, K., Debasitis, J. C., Maruggi, G., Otten, G. R., Geall, A. J., et al. (2017) · The Journal of Immunology
Immunotherapy and Immune Responsesinterferon and immune responses
Cited by 208
- Verified
Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice
Samsa, M. M., Dupuy, L. C., Beard, C. W., Six, C. M., Schmaljohn, C. S., Mason, P. W., Geall, A. J., Ulmer, J. B., & Yu, D. (2019) · Molecular Therapy
Mosquito-borne diseases and controlRNA Interference and Gene Delivery
Cited by 63
- Verified
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation
Sponholtz, M. R., Byrne, P. O., Lee, A. G., Ramamohan, A. R., Goldsmith, J. A., McCool, R. S., Zhou, L., Johnson, N. V., Hsieh, C.-L., Connors, M., et al. (2024) · Proceedings of the National Academy of Sciences
Cytomegalovirus and herpesvirus researchViral Infectious Diseases and Gene Expression in Insects
Cited by 37
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free